A retrospective study to assess thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants
Latest Information Update: 16 Mar 2021
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Dabigatran etexilate (Primary) ; Warfarin (Primary)
- Indications Ischaemic stroke; Thromboembolism
- Focus Therapeutic Use
Most Recent Events
- 16 Mar 2021 New trial record